4.8 Review

Ionic Liquids: New Forms of Active Pharmaceutical Ingredients with Unique, Tunable Properties

期刊

CHEMICAL REVIEWS
卷 123, 期 20, 页码 11894-11953

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrev.3c00384

关键词

-

向作者/读者索取更多资源

This Review summarizes the advances in active pharmaceutical ingredient ionic liquids (API-ILs) over the last 15 years, focusing on their synthesis, characterization, and pharmaceutical applications. The article highlights the challenges and prospects in translating API-ILs into pharmaceutical manufacturing.
This Review aims to summarize advances over the last 15 years in the development of active pharmaceutical ingredient ionic liquids (API-ILs), which make up a prospective game-changing strategy to overcome multiple problems with conventional solid-state drugs, for example, polymorphism. A critical part of the present Review is the collection of API-ILs and deep eutectic solvents (DESs) prepared to date. The Review covers rules for rational design of API-ILs and tools for API-IL formation, syntheses, and characterization. Nomenclature and ionic speciation, and the confusion that these may cause, are highlighted, particularly for speciation in both ILs and DESs of intermediate ionicity. We also highlight in vivo and in vitro pharmaceutical activity studies, with differences in pharmacokinetic/pharmacodynamic depending on ionicity of API-ILs. A brief overview is provided for the ILs used to deliver drugs, and the Review concludes with key prospects and roadblocks in translating API-ILs into pharmaceutical manufacturing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据